Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (80)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hedrich, K.
Right arrow Articles by Klein, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedrich, K.
Right arrow Articles by Klein, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2001, Vol. 10, No. 16 1649-1656
© 2001 Oxford University Press

The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism

Katja Hedrich1,2, Martin Kann1,2, Andrea J. Lanthaler1,2,3, Andreas Dalski2, Cordula Eskelson1,2, Olfert Landt4, Eberhard Schwinger2, Peter Vieregge1, Anthony E. Lang5, Xandra O. Breakefield6, Laurie J. Ozelius7, Peter P. Pramstaller8 and Christine Klein1,2,+

1Department of Neurology and 2Department of Human Genetics, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany, 3Department of Hematology, Regional General Hospital, 39100 Bolzano, Italy, 4TIB MOLBIOL, 10829 Berlin, Germany, 5Division of Neurology, Department of Medicine, University of Toronto, and Toronto Western Hospital, Toronto M5T 2S8, Canada, 6Molecular Neurogenetics Unit, Massachusetts General Hospital, and Departments of Neurology and Neuroscience Program, Harvard Medical School, Boston, MA 02129, USA, 7Molecular Genetics, Albert Einstein College of Medicine, Bronx, NY 10461, USA and 8Department of Neurology, Regional General Hospital, 39100 Bolzano, Italy

Early-onset parkinsonism (EOP) may be associated with different mutations in the parkin gene, including exon deletions and duplications. To test for gene dosage alterations, we developed a new method of quantitative duplex PCR using the fluorescence resonance energy transfer technique on the LightCycler (Roche Diagnostics). In 21 patients with EOP, three mutations (a single base pair substitution in exon 3 and small deletions in exon 9) were detected by conventional mutational screening (single-strand conformation polymorphism and sequence analysis), while alterations of gene dosage were found in seven patients. We identified heterozygous and compound heterozygous deletions of exons 2, 3, 5 and 7. The latter was also found in the homozygous state. In addition, two heterozygous duplications of exon 4 were observed. Remarkably, two patients carried more than two parkin mutations. This is the first study systematically screening all 12 exons of parkin by real-time, kinetic quantification and clearly shows that mutational analysis of the parkin gene should include gene dosage studies. Furthermore, our method of quantitative PCR is easily applicable to any other gene to be screened for deletions or duplications of whole exons.

+ To whom correspondence should be addressed. Tel: +49 451 500 2993; Fax: +49 451 500 4861; Email: klein_ch@neuro.mu-luebeck.de The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
J Brooks, J Ding, J Simon-Sanchez, C Paisan-Ruiz, A B Singleton, and S W Scholz
Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control
J. Med. Genet., June 1, 2009; 46(6): 375 - 381.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Klein and M. G. Schlossmacher
Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Neurology, November 27, 2007; 69(22): 2093 - 2104.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
F. Asmus, L. E. Hjermind, E. Dupont, J. Wagenstaller, E. Haberlandt, M. Munz, T. M. Strom, and T. Gasser
Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype
Brain, October 1, 2007; 130(10): 2736 - 2745.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
C. Hampe, H. Ardila-Osorio, M. Fournier, A. Brice, and O. Corti
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity
Hum. Mol. Genet., July 1, 2006; 15(13): 2059 - 2075.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
M. Sun, J. C. Latourelle, G. F. Wooten, M. F. Lew, C. Klein, H. A. Shill, L. I. Golbe, M. H. Mark, B. A. Racette, J. S. Perlmutter, et al.
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study.
Arch Neurol, June 1, 2006; 63(6): 826 - 832.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
C. Klein
Implications of genetics on the diagnosis and care of patients with Parkinson disease.
Arch Neurol, March 1, 2006; 63(3): 328 - 334.
[Abstract] [Full Text] [PDF]

Home page
 Arch NeurolHome page
H. Deng, W.-D. Le, C. B. Hunter, W. G. Ondo, Y. Guo, W.-J. Xie, and J. Jankovic
Heterogeneous Phenotype in a Family With Compound Heterozygous Parkin Gene Mutations
Arch Neurol, February 1, 2006; 63(2): 273 - 277.
[Abstract] [Full Text] [PDF]

Home page
 BrainHome page
C. Buhmann, F. Binkofski, C. Klein, C. Buchel, T. van Eimeren, C. Erdmann, K. Hedrich, M. Kasten, J. Hagenah, G. Deuschl, et al.
Motor reorganization in asymptomatic carriers of a single mutant Parkin allele: a human model for presymptomatic parkinsonism
Brain, October 1, 2005; 128(10): 2281 - 2290.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurol. Neurosurg. PsychiatryHome page
B Schule, N Kock, M Svetel, N Dragasevic, K Hedrich, P de Carvalho Aguiar, L Liu, K Kabakci, J Garrels, E-M Meyer, et al.
Genetic heterogeneity in ten families with myoclonus-dystonia
J. Neurol. Neurosurg. Psychiatry, August 1, 2004; 75(8): 1181 - 1185.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Costa, J.-M. Jouannic, N. Stieltjes, J.-M. Costa, E. Girodon, and M. Goossens
Quantitative Real-Time PCR Assay for Rapid Identification of Deletion Carriers in Hemophilia
Clin. Chem., July 1, 2004; 50(7): 1269 - 1270.
[Full Text] [PDF]

Home page
 Hum Mol GenetHome page
I. F. Mata, P. J. Lockhart, and M. J. Farrer
Parkin genetics: one model for Parkinson's disease
Hum. Mol. Genet., April 1, 2004; 13(90001): R127 - 133.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Hedrich, A. Djarmati, N. Schafer, R. Hering, C. Wellenbrock, P. H. Weiss, R. Hilker, P. Vieregge, L. J. Ozelius, P. Heutink, et al.
DJ-1 (PARK7) mutations are less frequent than Parkin (PARK2) mutations in early-onset Parkinson disease
Neurology, February 10, 2004; 62(3): 389 - 394.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
K. Kabakci, K. Hedrich, J. C. Leung, M. Mitterer, P. Vieregge, R. Lencer, J. Hagenah, J. Garrels, K. Witt, F. Klostermann, et al.
Mutations in DYT1: Extension of the phenotypic and mutational spectrum
Neurology, February 10, 2004; 62(3): 395 - 400.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. F. Winklhofer, I. H. Henn, P. C. Kay-Jackson, U. Heller, and J. Tatzelt
Inactivation of Parkin by Oxidative Stress and C-terminal Truncations: A PROTECTIVE ROLE OF MOLECULAR CHAPERONES
J. Biol. Chem., November 21, 2003; 278(47): 47199 - 47208.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
N. Pankratz, W. C. Nichols, S. K. Uniacke, C. Halter, J. Murrell, A. Rudolph, C. W. Shults, P. M. Conneally, T. Foroud, and the Parkinson Study Group
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families
Hum. Mol. Genet., October 16, 2003; 12(20): 2599 - 2608.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
C. Klein, K. Hedrich, K. Kabakci, K. Mohrmann, K. Wiegers, O. Landt, J. Hagenah, E. Schwinger, P. P. Pramstaller, L. J. Ozelius, et al.
Exon deletions in the GCHI gene in two of four Turkish families with dopa-responsive dystonia
Neurology, December 10, 2002; 59(11): 1783 - 1786.
[Abstract] [Full Text] [PDF]

Home page
 NeurologyHome page
M. Kann, K. Hedrich, P. Vieregge, H. Jacobs, B. Muller, N. Kock, E. Schwinger, C. Klein, K. Marder, J. Harris, et al.
The parkin gene is not involved in late-onset Parkinson's disease
Neurology, March 12, 2002; 58(5): 835 - 835.
[Full Text] [PDF]

Home page
 Genome ResHome page
S. van Soest, J. Swart, N. Tijmes, L. A. Sandkuijl, J. Rommers, and A. A.B. Bergen
A Locus for Autosomal Recessive Pseudoxanthoma Elasticum, with Penetrance of Vascular Symptoms in Carriers, Maps to Chromosome 16p13.1
Genome Res., August 1, 1997; 7(8): 830 - 834.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.